If you ve recently had the J&J vaccine, watch for these rare symptoms, CDC says
Have you had the single-shot Johnson & Johnson Covid-19 vaccine within the last month?If you experience a severe headache that does not go away, signi.
Posted: Apr 13, 2021 6:21 PM
Posted By: CNN
Have you had the single-shot Johnson & Johnson Covid-19 vaccine within the last month?
If you experience a severe headache that does not go away, significant abdominal or leg pain that does not subside, or increasing shortness of breath, health officials want you to call your doctor immediately.
Those could be signs of an extremely rare, severe type of clot that may be linked to the Johnson & Johnson vaccine so rare that only six cases have been reported in the United States out of the approximately 7 million Johnson & Johnson doses administered to date.
FAIRFIELD-SUISUN, CALIFORNIA
Rocky Mountain Regional VA Medical Center investigational pharmacy technician Sara Berech is reflected in the glass of a fume hood as she prepares a dose of the Johnson & Johnson COVID-19 vaccine for a clinical trial on December 15, 2020, in Aurora, Colorado. (Michael Ciaglo/Getty Images/TNS)
Got the Johnson & Johnson Covid vaccine? Here’s what to do – and what you should know
Federal health officials urged vaccination centers across the country on Tuesday to pause their use of the Johnson & Johnson Covid-19 vaccine after six women – one of whom died and another who is in critical condition – developed blood clots within two weeks of vaccination.
(CNN)Have you had the single-shot Johnson & Johnson Covid-19 vaccine within the last month?
If you experience a severe headache that does not go away, significant abdominal or leg pain that does not subside, or increasing shortness of breath, health officials want you to call your doctor immediately.
Those could be signs of an extremely rare, severe type of clot that may be linked to the Johnson & Johnson vaccine so rare that only six cases have been reported in the United States out of the approximately 7 million Johnson & Johnson doses administered to date.
However, if you received the J&J vaccine more than a month ago, the risk is very low, said Dr. Anne Schuchat, principal deputy director of the US Centers for Disease Control and Prevention, during a virtual briefing on Tuesday.
Emory and NIH continue public-private partnership advancing Alzheimer’s research
The National Institutes of Health is launching the next version of AMP AD (Accelerating Medicines Partnership Alzheimer’s Disease), a public-private partnership that takes an open science, big data approach to identifying biological targets for therapeutic intervention.
The National Institute on Aging will lead research efforts for AMP AD 2.0 and has pledged to contribute $61.4 million over five years. This includes funding six multi-institutional, cross-disciplinary academic research teams, including the team at Goizueta Alzheimer’s Research Center at Emory University, along with a data coordinating center at Sage Bionetworks.
Emory researchers served as a founding academic team for the first iteration of the AMP AD when the initiative began in 2014. Led by Allan Levey and Nicholas T. Seyfried, Emory investigators will play an integral role in AMP AD 2.0 as it seeks to support new technologies,